Avedro Announces FDA Priority Review Status! – Corneal Cross-linking! This is huge news for the keratoconic community. The priority review status for the New Drug Application (NDA) places the application action date at March 15th, 2014.
Read MoreAvedro Announces FDA Priority Review Status! – Corneal Cross-linking! This is huge news for the keratoconic community. The priority review status for the New Drug Application (NDA) places the application action date at March 15th, 2014.
Read MoreThe NY Jets 2013 season has started out with a bang! Dr. Hersh was there, as the team ophthalmologist to witness the first win of the season!
Read MoreCongratulations to Dr. Peter Hersh for inclusion in Castle Connolly’s “Top Doctors” list for the New York Metro area. In addition to this high honor, Dr. Hersh is also noted as the top 1% in the nation in his specialty. Congrats Dr. Hersh!
Read MoreDr. Hersh and a team of eye surgeons visited Bogota, Colombia to perform surgery and review patients treated with a new LASIK procedure. This procedure combines LASIK with corneal collagen crosslinking. While LASIK vision correction surgery reshapes the cornea to improve nearsightedness, farsightedness, and astigmatism, collagen crosslinking uses a combination of riboflavin (vitamin B2) and […]
Read MoreDr. Hersh was invited to lecture at the International Congress of Corneal Cross-Linking in Geneva, Switzerland on December 7-8, 2012. He has had the honor of lecturing at this event multiple times. He discussed U.S. Crosslinking Clinical Trials, Corneal Biomechanics in Crosslinking and Predictors of Success for Crosslinking. The Cornea and Laser Eye Institute has […]
Read MoreMany laser centers have more than one surgeon who performs corrective eye surgery. We are proud to say that Dr. Peter Hersh is our ONLY LASIK surgeon. Here at The Cornea and Laser Eye Institute, we thrive to give our patients the best care possible. We feel that it is very important to know the […]
Read MoreDr. Hersh and colleagues have begun to analyze data from their patients who underwent CXL as part of an FDA clinical trial in order to devise a CXL algorithm. The article below was published in the June 1, 2012 issue of Ophthalmology Times.
Read MoreAt the CLEI Center for Keratoconus, Dr. Hersh and his staff are involved in a number of educational programs for keratoconus doctors and patients. In the Fall of 2012, we will sponsor our 8th Annual Keratoconus Patient Symposium in association with the National Keratoconus Foundation. In a very successful program last year, nearly 150 keratoconus […]
Read MoreDr. Hersh visited Moscow hospital this week to review results of new corneal cross-linking technique.
Read MoreIn the June issue of Journal of Refractive Surgery, Dr. Hersh’s article, “Effect of Topographic Cone Location on Outcomes of Corneal Collagen Cross-linking for Keratoconus and Corneal Ectasia.” Corneal collagen cross-linking is a treatment designed to decrease the progression of keratoconus and corneal ectasia. The purpose of the article is to assess the effect of […]
Read More